{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["biomarker", "immune response", "immunosuppression", "long non-coding RNA", "therapeutic target", "tumor microenvironment"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32083005", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "01", "Day": "31"}], "Language": ["eng"], "ELocationID": ["48", "10.3389/fonc.2020.00048"], "Journal": {"ISSN": "2234-943X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in oncology", "ISOAbbreviation": "Front Oncol"}, "ArticleTitle": "Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment.", "Pagination": {"StartPage": "48", "MedlinePgn": "48"}, "Abstract": {"AbstractText": ["Tumor immunosuppression may assist the immune escape of cancer cells, which promotes tumor metastasis and resistance to chemo-radiotherapy. The therapeutic strategies against tumor immunosuppression mainly focus on blocking immune checkpoint receptors, enhancing T-cell recognition and neutralizing inhibitory molecules. Although immunotherapies based on these strategies have improved the clinical outcomes, immunological nonresponse and resistance are two barriers to tumor eradication. Therefore, there is an urgent need to identify new biomarkers for patient selection and therapeutic targets for the development of combination regimen with immunotherapy. Recent studies have reported that non-protein-coding modulators exhibit important functions in post-transcriptional gene regulation, which subsequently modulates multiple pathophysiological processes, including neoplastic transformation. Differentiated from microRNAs, long non-coding RNAs (lncRNAs) are reported to be involved in various processes of the immune response in the tumor microenvironment (TME) to promote tumor immunosuppression. Currently, studies on tumor immunity regulated by lncRNAs are mainly confined to certain types of cancer cells or stromal cells. Additionally, the majority of studies are focused on the events involved in T cells and myeloid-derived suppressor cells (MDSCs). Although the reported studies have indicated the significance of lncRNAs in immunotherapy, the lack of comprehensive studies prevents us from exploring useful lncRNAs. In the current review, we have summarized the roles of lncRNAs in tumor immune response, and highlighted major lncRNAs as potential biomarkers or therapeutic targets for clinical application of immunotherapy."], "CopyrightInformation": "Copyright \u00a9 2020 Luo, Yang, Yu, Liu, Yu, Hu, Shi and Ma."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China."}], "LastName": "Luo", "ForeName": "Ya", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China."}, {"Identifier": [], "Affiliation": "Department of Breast Surgery, West China Hospital, Sichuan University, Chengdu, China."}], "LastName": "Yang", "ForeName": "Jiqiao", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China."}], "LastName": "Yu", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China."}], "LastName": "Liu", "ForeName": "Xiaowei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China."}], "LastName": "Yu", "ForeName": "Chune", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy and Biological Engineering, Sichuan Industrial Institute of Antibiotics, Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Chengdu University, Chengdu, China."}], "LastName": "Hu", "ForeName": "Jianping", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China."}], "LastName": "Shi", "ForeName": "Hubing", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Tumor Targeted and Immune Therapy, Clinical Research Center for Breast, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Biotherapy, Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China."}], "LastName": "Ma", "ForeName": "Xuelei", "Initials": "X"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867", "ISSNLinking": "2234-943X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. . Nivolumab versus docetaxel in advanced nonsquamous non\u2013small-cell lung cancer. N Engl J Med. (2015)1627\u201339. 10.1056/NEJMoa1507643", "ArticleIdList": ["10.1056/NEJMoa1507643", "PMC5705936", "26412456"]}, {"Citation": "Ferris RL, Blumenschein G, Jr, Fayette J, Guigay J, Colevas AD, Licitra L, et al. . Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. (2016) 375:1\u201312. 10.1056/NEJMoa1602252", "ArticleIdList": ["10.1056/NEJMoa1602252", "PMC5564292", "27718784"]}, {"Citation": "Mikkilineni L, Kochenderfer JN. Chimeric antigen receptor T-cell therapies for multiple myeloma. Blood. (2017) 130:2594\u2013603. 10.1182/blood-2017-06-793869", "ArticleIdList": ["10.1182/blood-2017-06-793869", "PMC5731088", "28928126"]}, {"Citation": "Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. (2012) 12:269\u2013281. 10.1038/nri3191", "ArticleIdList": ["10.1038/nri3191", "PMC6292222", "22437939"]}, {"Citation": "O'Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. (2018) 16:151\u201367. 10.1038/s41571-018-0142-8", "ArticleIdList": ["10.1038/s41571-018-0142-8", "30523282"]}, {"Citation": "Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. (2017) 541:321\u201330. 10.1038/nature21349", "ArticleIdList": ["10.1038/nature21349", "28102259"]}, {"Citation": "Hegde PS, Karanikas V, Evers S. The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition. Clin Cancer Res. (2016) 22:1865\u201374. 10.1158/1078-0432.CCR-15-1507", "ArticleIdList": ["10.1158/1078-0432.CCR-15-1507", "27084740"]}, {"Citation": "Tumeh PC, Harview CL, Yearley JH, Shintaku IP, Taylor EJM, Robert L, et al. . PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature. (2014) 515:568\u201371. 10.1038/nature13954", "ArticleIdList": ["10.1038/nature13954", "PMC4246418", "25428505"]}, {"Citation": "Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy : mechanisms, response biomarkers, and combinations. Sci Transl Med. (2016) 8:328rv4. 10.1126/scitranslmed.aad7118", "ArticleIdList": ["10.1126/scitranslmed.aad7118", "PMC4859220", "26936508"]}, {"Citation": "Pitt JM, Ve'Tizou M, Daille R, Roberti P, Yamazaki T, Pitt JM, et al. Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors. Immunity. (2016) 28:1255\u201369. 10.1016/j.immuni.2016.06.001", "ArticleIdList": ["10.1016/j.immuni.2016.06.001", "27332730"]}, {"Citation": "Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, et al. . Pan-tumor genomic biomarkers for PD-1 checkpoint blockade\u2013based immunotherapy. Science. (2018) 362:eaar3593. 10.1126/science.aar3593", "ArticleIdList": ["10.1126/science.aar3593", "PMC6718162", "30309915"]}, {"Citation": "Leone P, Shin E, Perosa F, Vacca A, Dammacco F, Racanelli V. MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells. J Natl Cancer Inst. (2013) 105:1172\u201387. 10.1093/jnci/djt184", "ArticleIdList": ["10.1093/jnci/djt184", "23852952"]}, {"Citation": "Eichm\u00fcller SB, Osen W, Mandelboim O, Seliger B. Immune modulatory microRNAs involved in tumor attack and tumor immune escape. J Natl Cancer Inst. (2017) 109:1\u201314. 10.1093/jnci/djx034", "ArticleIdList": ["10.1093/jnci/djx034", "28383653"]}, {"Citation": "Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. (2012) 12:253\u201368. 10.1038/nri3175", "ArticleIdList": ["10.1038/nri3175", "PMC3587148", "22437938"]}, {"Citation": "Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. (2009) 9:162\u201374. 10.1038/nri2506", "ArticleIdList": ["10.1038/nri2506", "PMC2828349", "19197294"]}, {"Citation": "Appay V, Douek DC, Price DA. CD8+ T cell efficacy in vaccination and disease. Nat Med. (2008) 14:623\u20138. 10.1038/nm.f.1774", "ArticleIdList": ["10.1038/nm.f.1774", "18535580"]}, {"Citation": "Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. (2012) 12:252\u201364. 10.1038/nrc3239", "ArticleIdList": ["10.1038/nrc3239", "PMC4856023", "22437870"]}, {"Citation": "Toor SM, Sasidharan Nair V, Decock J, Elkord E. Immune checkpoints in the tumor microenvironment. Semin Cancer Biol. (2019) 10.1016/j.semcancer.2019.06.021", "ArticleIdList": ["10.1016/j.semcancer.2019.06.021", "31265893"]}, {"Citation": "Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. (2005) 7:211\u20137. 10.1016/j.ccr.2005.02.013", "ArticleIdList": ["10.1016/j.ccr.2005.02.013", "15766659"]}, {"Citation": "Palucka AK, Coussens LM. The basis of oncoimmunology. Cell. (2016) 164:1233\u201347. 10.1016/j.cell.2016.01.049", "ArticleIdList": ["10.1016/j.cell.2016.01.049", "PMC4788788", "26967289"]}, {"Citation": "Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. (2016) 27:1482\u201392. 10.1093/annonc/mdw168", "ArticleIdList": ["10.1093/annonc/mdw168", "27069014"]}, {"Citation": "Atianand MK, Fitzgerald KA. Long non-coding rnas and control of gene expression in the immune system. Trends Mol Med. (2014) 20:623\u201331. 10.1016/j.molmed.2014.09.002", "ArticleIdList": ["10.1016/j.molmed.2014.09.002", "PMC4252818", "25262537"]}, {"Citation": "Sun Z, Yang S, Zhou Q, Wang G, Song J, Li Z, et al. . Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment. Mol Cancer. (2018) 17:82. 10.1186/s12943-018-0831-z", "ArticleIdList": ["10.1186/s12943-018-0831-z", "PMC5909226", "29678180"]}, {"Citation": "Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. (2011) 43:904\u201314. 10.1016/j.molcel.2011.08.018", "ArticleIdList": ["10.1016/j.molcel.2011.08.018", "PMC3199020", "21925379"]}, {"Citation": "Atianand MK, Caffrey DR, Fitzgerald KA. Immunobiology of Long Noncoding RNAs. Annu Rev Immunol. (2017) 35:177\u201398. 10.1146/annurev-immunol-041015-055459", "ArticleIdList": ["10.1146/annurev-immunol-041015-055459", "PMC6449690", "28125358"]}, {"Citation": "Hu Q, Ye Y, Chan LC, Li Y, Liang K, Lin A, et al. . Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression. Nat Immunol. (2019) 20:835\u201351. 10.1038/s41590-019-0400-7", "ArticleIdList": ["10.1038/s41590-019-0400-7", "PMC6619502", "31160797"]}, {"Citation": "Grote P, Wittler L, Hendrix D, Koch F, W\u00e4hrisch S, Beisaw A, et al. . The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. (2013) 24:206\u201314. 10.1016/j.devcel.2012.12.012", "ArticleIdList": ["10.1016/j.devcel.2012.12.012", "PMC4149175", "23369715"]}, {"Citation": "Xu J, Shi A, Long Z, Xu L, Liao G, Deng C, et al. . Capturing functional long non-coding RNAs through integrating large-scale causal relations from gene perturbation experiments. EBioMedicine. (2018) 35:369\u201380. 10.1016/j.ebiom.2018.08.050", "ArticleIdList": ["10.1016/j.ebiom.2018.08.050", "PMC6156711", "30177244"]}, {"Citation": "Zhang Y, Liao G, Bai J, Zhang X, Xu L, Deng C, et al. . Identifying cancer driver lncRNAs bridged by functional effectors through integrating multi-omics data in human cancers. Mol Ther. (2019) 17:362\u201373. 10.1016/j.omtn.2019.05.030", "ArticleIdList": ["10.1016/j.omtn.2019.05.030", "PMC6626872", "31302496"]}, {"Citation": "Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. (2012) 81:145\u201366. 10.1146/annurev-biochem-051410-092902", "ArticleIdList": ["10.1146/annurev-biochem-051410-092902", "PMC3858397", "22663078"]}, {"Citation": "Guttman M, Amit I, Garber M, French C, Lin MF, Huarte M, et al. . Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. (2009) 458:223\u20137. 10.1038/nature07672", "ArticleIdList": ["10.1038/nature07672", "PMC2754849", "19182780"]}, {"Citation": "Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M, Tonlorenzi R, et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature. (1991) 349:38\u201344. 10.1038/349038a0", "ArticleIdList": ["10.1038/349038a0", "1985261"]}, {"Citation": "Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol. (1989) 10:28\u201336. 10.1128/MCB.10.1.28", "ArticleIdList": ["10.1128/MCB.10.1.28", "PMC360709", "1688465"]}, {"Citation": "Pei X, Wang X, Li H. LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO. Int J Biol Macromol. (2018) 118:24\u201330. 10.1016/j.ijbiomac.2018.06.033", "ArticleIdList": ["10.1016/j.ijbiomac.2018.06.033", "29886172"]}, {"Citation": "Wang S, Yang L, Lin C, Wang S, Liang K, Hu Q, et al. . JAK2-binding long noncoding RNA promotes breast cancer brain metastasis. J Clin Invest. (2017) 127:4498\u2013515. 10.1172/JCI91553", "ArticleIdList": ["10.1172/JCI91553", "PMC5707156", "29130936"]}, {"Citation": "Rocha ST, Heard E. Novel players in X inactivation : insights into Xist -mediated gene silencing and chromosome conformation. Nat Publ Gr. (2017) 24:197\u2013204. 10.1038/nsmb.3370", "ArticleIdList": ["10.1038/nsmb.3370", "28257137"]}, {"Citation": "Li X, Lei Y, Wu M, Li N. Regulation of macrophage activation and polarization by HCC-derived exosomal lncRNA TUC339. Int J Mol Sci. (2018) 19:1\u201319. 10.3390/ijms19102958", "ArticleIdList": ["10.3390/ijms19102958", "PMC6213212", "30274167"]}, {"Citation": "Ding L, Ren J, Zhang D, Li Y, Huang X, Hu Q, et al. . A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33. Carcinogenesis. (2018) 39:397\u2013406. 10.1093/carcin/bgy006", "ArticleIdList": ["10.1093/carcin/bgy006", "29346528"]}, {"Citation": "Whiteside TL. Exosomes and tumor-mediated immune suppression. J Clin Invest. (2016) 126:1216\u201323. 10.1172/JCI81136", "ArticleIdList": ["10.1172/JCI81136", "PMC4811135", "26927673"]}, {"Citation": "Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y, et al. . Extracellular vesicle-packaged HIF-1\u03b1-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. (2019) 21:498\u2013510. 10.1038/s41556-019-0299-0", "ArticleIdList": ["10.1038/s41556-019-0299-0", "30936474"]}, {"Citation": "Wang X, Shen H, He Q, Tian W, Xia A, Lu XJ. Exosomes derived from exhausted CD8 + T cells impaired the anticancer function of normal CD8 + T cells. J Med Genet. (2019) 56:29\u201331. 10.1136/jmedgenet-2018-105439", "ArticleIdList": ["10.1136/jmedgenet-2018-105439", "29997128"]}, {"Citation": "Kan J-Y, Wu D-C, Yu F-J, Wu C-Y, Ho Y-W, Chiu Y-J, et al. . Chemokine (C-C Motif) ligand 5 cancer progression through dendritic cell-mediated colon is involved in tumor-associated non-coding RNA MALAT-1. J Cell Physiol. (2015) 230:1883\u201394. 10.1002/jcp.24918", "ArticleIdList": ["10.1002/jcp.24918", "25546229"]}, {"Citation": "Denaro N, Merlano MC, Nigro C Lo. Long noncoding RNAs as regulators of cancer immunity. Mol Oncol. (2019) 13:61\u201373. 10.1002/1878-0261.12413", "ArticleIdList": ["10.1002/1878-0261.12413", "PMC6322193", "30499165"]}, {"Citation": "Xing F, Liu Y, Wu S, Wu K, Sharma S, Mo Y, et al. . Loss of XIST in breast cancer activates MSN-c-met and reprograms microglia via exosomal miRNA to promote brain metastasis. Cancer Res. (2018) 78:4316\u201330. 10.1158/0008-5472.CAN-18-1102", "ArticleIdList": ["10.1158/0008-5472.CAN-18-1102", "PMC6072593", "30026327"]}, {"Citation": "Chen C, He W, Huang J, Wang B, Li H, Cai Q, et al. . LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. Nat Commun. (2018) 9:3826. 10.1038/s41467-018-06152-x", "ArticleIdList": ["10.1038/s41467-018-06152-x", "PMC6148066", "30237493"]}, {"Citation": "Huang D, Chen J, Yang L, Ouyang Q, Li J, Lao L, et al. . NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death. Nat Immunol. (2018) 19:1112\u201325. 10.1038/s41590-018-0207-y", "ArticleIdList": ["10.1038/s41590-018-0207-y", "30224822"]}, {"Citation": "Sun J, Ji J, Huo G, Song Q, Zhang X. Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer. Int J Oncol. (2016)943\u201352 10.3892/ijo.2016.3589", "ArticleIdList": ["10.3892/ijo.2016.3589", "27574106"]}, {"Citation": "Zhang J, Wang Q, Quan Z. Long non-coding RNA CASC9 enhances breast cancer progression by promoting metastasis through the meditation of miR-215/TWIST2 signaling associated with TGF-b expression. Biochem Biophys Res Commun. (2019) 515:644\u201350. 10.1016/j.bbrc.2019.05.080", "ArticleIdList": ["10.1016/j.bbrc.2019.05.080", "31178137"]}, {"Citation": "Li Y, Li Y, Huang S, He K, Zhao M, Lin H. Long non-coding RNA growth arrest specific transcript 5 acts as a tumour suppressor in colorectal cancer by inhibiting interleukin-10 and vascular endothelial growth factor expression. Oncotarget. (2017) 8:13690\u2013702. 10.18632/oncotarget.14625", "ArticleIdList": ["10.18632/oncotarget.14625", "PMC5355130", "28099146"]}, {"Citation": "Wu K, Zhao Z, Liu K, Zhang J, Li G. Long noncoding RNA lnc-sox5 modulates CRC tumorigenesis by unbalancing tumor microenvironment. Cell Cycle. (2017) 16:1295\u2013301. 10.1080/15384101.2017.1317416", "ArticleIdList": ["10.1080/15384101.2017.1317416", "PMC5531622", "28632999"]}, {"Citation": "Wang QM, Lian GY, Song Y, Huang YF, Gong Y. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. (2019) 231:116335. 10.1016/j.lfs.2019.03.040", "ArticleIdList": ["10.1016/j.lfs.2019.03.040", "30898647"]}, {"Citation": "Zhou AY, Zhao W, Mao L. Long non-coding RNA NIFK-AS1 inhibits M2 polarization of macrophages in endometrial cancer through targeting miR-146a. Int J Biochem Cell Biol. (2018) 104:25\u201333. 10.1016/j.biocel.2018.08.017", "ArticleIdList": ["10.1016/j.biocel.2018.08.017", "30176290"]}, {"Citation": "Zhang C, Jiang F, Su C, Xie P, Xu L. Upregulation of long noncoding RNA SNHG20 promotes cell growth and metastasis in esophageal squamous cell carcinoma via modulating ATM-JAK-PD-L1 pathway. J Cell Biochem. (2019) 120:11642\u201350. 10.1002/jcb.28444", "ArticleIdList": ["10.1002/jcb.28444", "30767270"]}, {"Citation": "Zhang H, Hua Y, Jiang Z, Yue J, Shi M, Zhen X, et al. . Cancer associated fibroblasts-promoted LncRNA DNM3OS confers radioresistance by regulating DNA damage response in esophageal squamous cell carcinoma. Clin Cancer Res. (2018) 25:1989\u20132000. 10.1158/1078-0432.CCR-18-0773", "ArticleIdList": ["10.1158/1078-0432.CCR-18-0773", "30463848"]}, {"Citation": "He Z, You C, Zhao D. Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells. Biochem Biophys Res Commun. (2018) 500:569\u201376. 10.1016/j.bbrc.2018.04.091", "ArticleIdList": ["10.1016/j.bbrc.2018.04.091", "29655792"]}, {"Citation": "Dominic A, Laurence J. Coagulation factor X regulated by CASC2c recruited macrophages and induced M2 polarization in glioblastoma multiforme. Front Immunol. (2018) 9:1557 10.3389/fimmu.2018.01557", "ArticleIdList": ["10.3389/fimmu.2018.01557", "PMC6043648", "30034397"]}, {"Citation": "Guan Z, Song B, Liu F, Sun D, Wang K, Qu H. Long non-coding RNA HOTAIR promotes HLA-G expression via inhibiting miR-152 in gastric cancer cells. Biochem Biophys Res Commun. (2015) 464:807\u201313. 10.1016/j.bbrc.2015.07.040", "ArticleIdList": ["10.1016/j.bbrc.2015.07.040", "26187665"]}, {"Citation": "Wang C, Zhu C, Xu J, Wang M, Zhao W, Liu Q, et al. The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. (2019) 18:115 10.1186/s12943-019-1032-0", "ArticleIdList": ["10.1186/s12943-019-1032-0", "PMC6609402", "31272462"]}, {"Citation": "Yao Y, Jiang Q, Jiang L, Wu J, Zhang Q. Lnc-SGK1 induced by Helicobacter pylori infection and high-salt diet promote Th2 and Th17 differentiation in human gastric cancer by SGK1/Jun B signaling. Oncotarget. (2016) 7:20549\u201360. 10.18632/oncotarget.7823", "ArticleIdList": ["10.18632/oncotarget.7823", "PMC4991474", "26942879"]}, {"Citation": "Xiong G, Yang L, Chen Y, Fan Z. Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution. Am J Transl Res. (2015) 7:2262\u20139.", "ArticleIdList": ["PMC4697706", "26807174"]}, {"Citation": "Yu Z, Zhao H, Feng X, Li H, Qiu C, Yi X, et al. Long non-coding RNA FENDRR acts as a miR-423-5p sponge to suppress the regulatory T cells-mediated immune escape of hepatocellular carcinoma cells. Am Soc Gene Cell Ther. (2019) 17:516\u201329. 10.1016/j.omtn.2019.05.027", "ArticleIdList": ["10.1016/j.omtn.2019.05.027", "PMC6661302", "31351327"]}, {"Citation": "Wu J, Zhang J, Shen B, Yin K, Xu J, Gao W, et al. . Long noncoding RNA lncTCF7, induced by IL-6 / STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J Exp Clin Cancer Res. (2015) 34:116. 10.1186/s13046-015-0229-3", "ArticleIdList": ["10.1186/s13046-015-0229-3", "PMC4600266", "26452542"]}, {"Citation": "Ji J, Yin Y, Ju H, Xu X, Liu W, Fu Q, et al. . Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC. Cell Death Dis. (2018) 9:478. 10.1038/s41419-018-0528-7", "ArticleIdList": ["10.1038/s41419-018-0528-7", "PMC5924754", "29706626"]}, {"Citation": "Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie Y, et al. . The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. (2017) 8:15129. 10.1038/ncomms15129", "ArticleIdList": ["10.1038/ncomms15129", "PMC5529670", "28541302"]}, {"Citation": "Yan K, Fu Y, Zhu N, Wang Z, Hong J, Li Y, et al. . Repression of lncRNA NEAT1 enhances the antitumor activity of CD8+T cells against hepatocellular carcinoma via regulating miR-155/Tim-3. Int J Biochem Cell Biol. (2019) 110:1\u20138. 10.1016/j.biocel.2019.01.019", "ArticleIdList": ["10.1016/j.biocel.2019.01.019", "30710754"]}, {"Citation": "Ye Y, Xu Y, Lai Y, He W, Li Y, Wang R, et al. . Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization. J Cell Biochem. (2017). 119:2951\u2013963. 10.1002/jcb.26509", "ArticleIdList": ["10.1002/jcb.26509", "29131381"]}, {"Citation": "Fang P, Xiang L, Chen W, Li S, Huang S, Li J, et al. . LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544 / RUNX3. Innate Immun. (2019) 25:99\u2013109. 10.1177/1753425919827632", "ArticleIdList": ["10.1177/1753425919827632", "PMC6830859", "30774011"]}, {"Citation": "Zheng Y, Tian X, Wang T, Xia X, Cao F, Tian J, et al. . Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Mol Cancer. (2019) 18:1\u201312. 10.1186/s12943-019-0978-2", "ArticleIdList": ["10.1186/s12943-019-0978-2", "PMC6441229", "30925926"]}, {"Citation": "Wei S, Wang K, Huang X, Zhao Z, Zhao Z. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis. Int J Immunopathol Pharmacol. (2019) 33:205873841985969. 10.1177/2058738419859699", "ArticleIdList": ["10.1177/2058738419859699", "PMC6595645", "31240979"]}, {"Citation": "Kathuria H, Millien G, McNally L, Gower AC, Tagne J, Cao Y, et al. . NKX2-1-AS1 negatively regulates CD274/PD-L1, cell-cell interaction genes, and limits human lung carcinoma cell migration. Sci Rep. (2018) 8:14418. 10.1038/s41598-018-32793-5", "ArticleIdList": ["10.1038/s41598-018-32793-5", "PMC6158174", "30258080"]}, {"Citation": "Zhou Q, Tang X, Tian X, Tian J, Zhang Y, Ma J, et al. . LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer. J Cancer. (2018) 9:2436\u201342. 10.7150/jca.24796", "ArticleIdList": ["10.7150/jca.24796", "PMC6036894", "30026840"]}, {"Citation": "Tian X, Jie M, Ting W, Yue Z, Lingxiang M, Huaxi X, et al. . Long non-coding RNA HOXA transcript antisense RNA myeloid-specific 1\u2013HOXA1 axis downregulates the immunosuppressive activity of myeloid-derived suppressor cells in lung cancer. Front Immunol. (2018) 9:473. 10.3389/fimmu.2018.00473", "ArticleIdList": ["10.3389/fimmu.2018.00473", "PMC5890118", "29662483"]}, {"Citation": "Tian X, Zhang Y, Mao L, Wang S, Ma J, Tian J, et al. . Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer. BMC Cancer. (2018) 18:1\u201310. 10.1186/s12885-018-4564-6", "ArticleIdList": ["10.1186/s12885-018-4564-6", "PMC6006856", "29914443"]}, {"Citation": "Tang Y, He Y, Shi L, Yang L, Wang J, Lian Y. Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma. Oncotarget. (2017) 8:39001\u201311. 10.18632/oncotarget.16545", "ArticleIdList": ["10.18632/oncotarget.16545", "PMC5503590", "28380458"]}, {"Citation": "Zeng X, Xie H, Yuan J, Jiang X, Yong J, Zeng D, et al. . EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression. Cancer Biol Ther. (2019) 20:956\u201366. 10.1080/15384047.2018.1564567", "ArticleIdList": ["10.1080/15384047.2018.1564567", "PMC6606001", "31062668"]}, {"Citation": "Cao J, Dong R, Jiang L, Gong Y, Yuan M, You J, et al. . LncRNA-MM2P identified as a modulator of macrophage M2 polarization. Cancer Immunol Res. (2019) 7:292\u2013305. 10.1158/2326-6066.CIR-18-0145", "ArticleIdList": ["10.1158/2326-6066.CIR-18-0145", "30459152"]}, {"Citation": "Zhou W-Y, Zhang M-M, Liu C, Kang Y, Wang J-O, Yang X-H. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p. J Cell Physiol. (2019) 1:1\u201314. 10.1002/jcp.28884", "ArticleIdList": ["10.1002/jcp.28884", "31206665"]}, {"Citation": "Zheng T, Ma G, Tang M, Li Z, Xu R. IL-8 secreted from M2 macrophages promoted prostate tumorigenesis via STAT3/MALAT1 pathway. Int J Mol Sci. (2019) 20:1\u201316. 10.3390/ijms20010098", "ArticleIdList": ["10.3390/ijms20010098", "PMC6337597", "30591689"]}, {"Citation": "Liu J, Ding D, Jiang Z, Du T. Long non-coding RNA CCAT1/miR-148a/PKC \u03b6 prevents cell migration of prostate cancer by altering macrophage polarization. Prostate. (2019) 79:105\u201312. 10.1002/pros.23716", "ArticleIdList": ["10.1002/pros.23716", "30221381"]}, {"Citation": "Huang J, Song W, Lu B, Huang Y, Dong H, Zhu Z, et al. . LncRNA-MALAT1 promotes angiogenesis of thyroid cancer by modulating tumor-associated macrophage FGF2 protein secretion. J Cell Biochem. (2017) 118:4821\u201330. 10.1002/jcb.26153", "ArticleIdList": ["10.1002/jcb.26153", "28543663"]}, {"Citation": "Gao Y, Wang T, Li Y, Zhang Y, Yang R, Alerts E. Lnc-chop promotes immunosuppressive function of myeloid-derived suppressor cells in tumor and inflammatory environments. J Immunol. (2019) 200:2603\u201314. 10.4049/jimmunol.1701721", "ArticleIdList": ["10.4049/jimmunol.1701721", "29531162"]}, {"Citation": "Johnsen AK, Templeton DJ, Harding CV, Alerts E. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J Immunol. (1999) 163:4224\u201331.", "ArticleIdList": ["10510359"]}, {"Citation": "Lin A, Li C, Xing Z, Hu Q, Liang K, Han L. The LINK-A lncRNA activates normoxic HIF1\u03b1 signaling in triple-negative breast cancer. Nat Cell Biol. (2016) 18:213\u201324. 10.1038/ncb3295", "ArticleIdList": ["10.1038/ncb3295", "PMC4791069", "26751287"]}, {"Citation": "Lin A, Hu Q, Li C, Xing Z, Ma G, Wang C, et al. . The LINK-A lncRNA interacts with PtdIns (3,4,5) P3 to hyperactivate AKT and confer resistance to AKT inhibitors. Nat Cell Biol. (2017) 19:238\u201351. 10.1038/ncb3473", "ArticleIdList": ["10.1038/ncb3473", "PMC5332298", "28218907"]}, {"Citation": "Bukur J, Jasinski S, Seliger B. The role of classical and non-classical HLA class I antigens in human tumors. Semin Cancer Biol. (2012) 22:350\u20138. 10.1016/j.semcancer.2012.03.003", "ArticleIdList": ["10.1016/j.semcancer.2012.03.003", "22465194"]}, {"Citation": "Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet A, et al. . VEGF-A modulates expression of inhibitory checkpoints on CD8 + T cells in tumors. J Exp Med. (2015) 212:139\u201348. 10.1084/jem.20140559", "ArticleIdList": ["10.1084/jem.20140559", "PMC4322048", "25601652"]}, {"Citation": "Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, et al. . Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med. (1996) 2:1096\u2013103. 10.1038/nm1096-1096", "ArticleIdList": ["10.1038/nm1096-1096", "8837607"]}, {"Citation": "Terme M, Pernot S, Marcheteau E, Sandoval F, Benhamouda N, Colussi O, et al. VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer. Cancer Res. (2013) 72:539\u201349. 10.1158/0008-5472.CAN-12-2325", "ArticleIdList": ["10.1158/0008-5472.CAN-12-2325", "23108136"]}, {"Citation": "Ruffell B, Chang-strachan D, Chan V, Rosenbusch A, Ho CMT, Pryer N, et al. . Macrophage IL-10 blocks CD8+T cell-dependentresponses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell. (2014) 26:623\u201337. 10.1016/j.ccell.2014.09.006", "ArticleIdList": ["10.1016/j.ccell.2014.09.006", "PMC4254570", "25446896"]}, {"Citation": "Shi X, Sun M, Liu H, Yao Y, Kong R, Chen F, et al. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog. (2015) 51:E1\u20132. 10.1002/mc.22120", "ArticleIdList": ["10.1002/mc.22120", "24357161"]}, {"Citation": "Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. (2008) 28:195\u2013208. 10.1038/onc.2008.373", "ArticleIdList": ["10.1038/onc.2008.373", "18836484"]}, {"Citation": "Mou Y, Wang D, Xing R, Nie H, Mou Y, Zhang Y. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma. Cancer Biomark. (2018) 23:95\u2013106. 10.3233/CBM-181424", "ArticleIdList": ["10.3233/CBM-181424", "29991128"]}, {"Citation": "Luo Y, Boyle DL, Hammaker D, Edgar M, Franzoso G, Firestein GS. Suppression of collagen-induced arthritis in growth arrest and DNA damage-inducible protein 45\u03b2-deficient mice. Arthritis Rheum. (2011) 63:2949\u201355. 10.1002/art.30497", "ArticleIdList": ["10.1002/art.30497", "PMC3183142", "21702006"]}, {"Citation": "Carpenter S, Fitzgerald KA. Cytokines and long noncoding RNAs. Cold Spring Harb Perspect Biol. (2018) 10:1\u201320. 10.1101/cshperspect.a028589", "ArticleIdList": ["10.1101/cshperspect.a028589", "PMC5983188", "28716885"]}, {"Citation": "Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM) -targeted therapeutics. Adv Drug Deliv Rev. (2017) 114:206\u201321. 10.1016/j.addr.2017.04.010", "ArticleIdList": ["10.1016/j.addr.2017.04.010", "PMC5581987", "28449873"]}, {"Citation": "Murray PJ. Macrophage polarization. Annu Rev Physiol. (2017) 79:541\u201366. 10.1146/annurev-physiol-022516-034339", "ArticleIdList": ["10.1146/annurev-physiol-022516-034339", "27813830"]}, {"Citation": "Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, Mantovani A. Macrophage polarization : tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. (2002) 23:549\u201355. 10.1016/S1471-4906(02)02302-5", "ArticleIdList": ["10.1016/S1471-4906(02)02302-5", "12401408"]}, {"Citation": "Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, et al. . CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. (2013) 19:1264\u201372. 10.1038/nm.3337", "ArticleIdList": ["10.1038/nm.3337", "PMC3840724", "24056773"]}, {"Citation": "Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, et al. . \u201cRe-educating\u201d tumor-associated macrophages by targeting NF-\u03baB. J Exp Med. (2008) 205:1261\u20138. 10.1084/jem.20080108", "ArticleIdList": ["10.1084/jem.20080108", "PMC2413024", "18490490"]}, {"Citation": "Zhu Y, Knolhoff BL, Meyer MA, Nywening TM, West BL, Luo J, et al. . CSF1 / CSF1R blockade reprograms tumor-in fi ltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. (2014) 74:5057\u201369. 10.1158/0008-5472.CAN-13-3723", "ArticleIdList": ["10.1158/0008-5472.CAN-13-3723", "PMC4182950", "25082815"]}, {"Citation": "Li Z, Feng C, Guo J, Hu X, Xie D. GNAS-AS1 / miR-4319 / NECAB3 axis promotes migration and invasion of non-small cell lung cancer cells by altering macrophage polarization. Funct Integr Genomics. (2019) 20:17\u201328. 10.1007/s10142-019-00696-x", "ArticleIdList": ["10.1007/s10142-019-00696-x", "31267263"]}, {"Citation": "Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL, et al. . A long noncoding RNA mediatesboth activation and repressionof immune response genes. Science. (2013) 341:789\u201392. 10.1126/science.1240925", "ArticleIdList": ["10.1126/science.1240925", "PMC4376668", "23907535"]}, {"Citation": "Li N. LncRNA MIR155HG regulates M1 / M2 macrophage polarization in chronic obstructive pulmonary disease. Biomed Pharmacother. (2019) 117:109015. 10.1016/j.biopha.2019.109015", "ArticleIdList": ["10.1016/j.biopha.2019.109015", "31207576"]}, {"Citation": "Marvel D, Gabrilovich DI, Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest. (2015) 125:3356\u201364. 10.1172/JCI80005", "ArticleIdList": ["10.1172/JCI80005", "PMC4588239", "26168215"]}, {"Citation": "Bunt SK, Sinha P, Clements VK, Ostrand-rosenberg S, Bunt SK, Sinha P, et al. . Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol. (2006) 176:284\u201390. 10.4049/jimmunol.176.1.284", "ArticleIdList": ["10.4049/jimmunol.176.1.284", "16365420"]}, {"Citation": "Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-rosenberg S. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. (2007) 67:10019\u201327. 10.1158/0008-5472.CAN-07-2354", "ArticleIdList": ["10.1158/0008-5472.CAN-07-2354", "PMC4402704", "17942936"]}, {"Citation": "Thevenot PT, Sierra RA, Raber PL, Al-khami AA, Trillo-tinoco J, Zarreii P, et al. . The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors. Immunity. (2014) 41:389\u2013401. 10.1016/j.immuni.2014.08.015", "ArticleIdList": ["10.1016/j.immuni.2014.08.015", "PMC4171711", "25238096"]}, {"Citation": "Corzo CA, Cotter MJ, Cheng P, Kusmartsev S, Sotomayor E, McCaffrey TV, et al. Mechanism regulating reactive oxygen species intumor-induced myeloid-derived suppressor cells. J Immunol. (2009) 182:5693\u2013701. 10.4049/jimmunol.0900092", "ArticleIdList": ["10.4049/jimmunol.0900092", "PMC2833019", "19380816"]}, {"Citation": "Jiang T, Shi T, Zhang H, Hu J, Song Y, Wei J, et al. Tumor neoantigens : from basic research to clinical applications. J Hematol Oncol. (2019) 5:1\u201313. 10.1186/s13045-019-0787-5", "ArticleIdList": ["10.1186/s13045-019-0787-5", "PMC6731555", "31492199"]}, {"Citation": "Jia AH, Truica CI, Wang B. Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects. Drug Resist Updat. (2017) 32:1\u201315. 10.1016/j.drup.2017.07.002", "ArticleIdList": ["10.1016/j.drup.2017.07.002", "29145974"]}, {"Citation": "Wang X, S\u00e9n\u00e9chal B, Curran KJ, Sauter C, Wang Y, Santomasso B, et al. . Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med. (2018) 378:449\u201359. 10.1056/NEJMoa1709919", "ArticleIdList": ["10.1056/NEJMoa1709919", "PMC6637939", "29385376"]}, {"Citation": "Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, et al. . Chimeric antigen receptor\u2013modified T cells for acute lymphoid leukemia. N Engl J Med. (2013) 368:1509\u201318. 10.1056/NEJMoa1215134", "ArticleIdList": ["10.1056/NEJMoa1215134", "PMC4058440", "23527958"]}, {"Citation": "Bagg A, June CH. Chimeric antigen receptor\u2013modified T cells in chronic lymphoid leukemia. N Engl J Med. (2011) 365:725\u201333. 10.1056/NEJMoa1103849", "ArticleIdList": ["10.1056/NEJMoa1103849", "PMC3387277", "21830940"]}, {"Citation": "Aplenc R, Barrett DM, Bunin NJ, Chew A, Gonzalez VE, Zheng Z, et al. . Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. (2014) 371:1507\u201317. 10.1056/NEJMoa1407222", "ArticleIdList": ["10.1056/NEJMoa1407222", "PMC4267531", "25317870"]}, {"Citation": "Mardiana S, Solomon BJ, Darcy PK, Beavis PA. Supercharging adoptive T cell therapy to overcome solid tumor \u2013 induced immunosuppression. Sci Transl Med. (2019) 11: eaaw2293. 10.1126/scitranslmed.aaw2293", "ArticleIdList": ["10.1126/scitranslmed.aaw2293", "31167925"]}, {"Citation": "Ahmed N, Brawley VS, Hegde M, Robertson C, Ghazi A, Gerken C, et al. Human epidermal growth factor receptor 2 (HER2) \u2013specific chimeric antigen receptor\u2013modified T cells for the immunotherapy ofHER2-positive sarcoma. J Clin Oncol. (2015) 33:1688\u201396. 10.1200/JCO.2014.58.0225", "ArticleIdList": ["10.1200/JCO.2014.58.0225", "PMC4429176", "25800760"]}, {"Citation": "Berger AC, Korkut A, Kanchi RS, Hegde AM, Lenoir W, Liu W, et al. . A comprehensive pan-cancer molecular study of gynecologic and breast cancers. Cancer Cell. (2018) 33:690\u2013705.e9. 10.1016/j.ccell.2018.03.014", "ArticleIdList": ["10.1016/j.ccell.2018.03.014", "PMC5959730", "29622464"]}]}], "History": [{"Year": "2019", "Month": "9", "Day": "26"}, {"Year": "2020", "Month": "1", "Day": "13"}, {"Year": "2020", "Month": "2", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "23", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32083005", "PMC7005925", "10.3389/fonc.2020.00048"]}}]}